The Global Monoclonal Antibodies market report is a recent research added by DecisionDatabases.com, offers critical insight into the market dynamic. This report also assays delicate market issue such as drivers, restraints, and opportunities along with their effect on the growth of the market. The report also discloses the analysis of present industry trends and opportunities of the market. Furthermore, the market insight offered in this report covers exhaustive study and valuable insight on comprehensive profiles of the key players in the market and crucial view of the competitive landscape worldwide.
Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.
This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.
The global Monoclonal Antibodies market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Monoclonal Antibodies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Monoclonal Antibodies market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
- AbbVie
- Roche
- Johnson & Johnson
- Amgen
- Merck
- BMS
- Eli Lilly
- Formation Biologics
- Genmab
- GlaxoSmithKline
- Human Genome Sciences
- mmunogen
- MedImmune
- Novartis
- Pfizer
- Seattle Genetics
- Stemcentrx
- Synthon Biopharmaceuticals
- Takeda
- Teva
Segment by Regions
- North America
- Europe
- China
- Japan
Segment by Type
- Cancer
- Autoimmune Diseases
- Infection
- Hematological Diseases
- Others
Segment by Application
- Oncology
- Autoimmune and inflammatory diseases
- Respiratory diseases
- Ophthalmology
Table of Contents-Snapshot
- Executive Summary
Chapter 1 Industry Overview
Chapter 2 Industry Competition by Manufacturers
Chapter 3 Industry Production Market Share by Regions
Chapter 4 Industry Consumption by Regions
Chapter 5 Industry Production, Revenue, Price Trend by Type
Chapter 6 Industry Analysis by Applications
Chapter 7 Company Profiles and Key Figures in Industry Business
Chapter 8 Industry Manufacturing Cost Analysis
Chapter 9 Marketing Channel, Distributors and Customers
Chapter 10 Market Dynamics
Chapter 11 Industry Forecast
Chapter 12 Research Findings and Conclusion
Chapter 13 Methodology and Data Source